A Moving Residual Limb: Botulinum Toxin to the Rescue

Movement disorders post-amputation are a rare complication and can manifest as the jumping stump phenomenon, a form of peripheral myoclonus. The pathophysiology remains unknown and there is currently no standardized treatment. We describe the case of a 57-year-old male with unremitting stump myoclon...

Full description

Bibliographic Details
Main Authors: Briand Marie-Michèle, Boudier-Réveret Mathieu, Rodrigue Xavier, Sirois Geneviève, Chang Min Cheol
Format: Article
Language:English
Published: De Gruyter 2020-02-01
Series:Translational Neuroscience
Subjects:
Online Access:https://doi.org/10.1515/tnsci-2020-0006
id doaj-1c419959fbf14b71b2eaa2673d4d2810
record_format Article
spelling doaj-1c419959fbf14b71b2eaa2673d4d28102021-09-05T20:51:32ZengDe GruyterTranslational Neuroscience2081-69362020-02-01111343710.1515/tnsci-2020-0006tnsci-2020-0006A Moving Residual Limb: Botulinum Toxin to the RescueBriand Marie-Michèle0Boudier-Réveret Mathieu1Rodrigue Xavier2Sirois Geneviève3Chang Min Cheol4Institut de réadaptation en déficience physique de Québec, Québec, CanadaDepartment of Physical Medicine and Rehabilitation, Centre hospitalier de l'Université de Montréal, Montreal, CanadaInstitut de réadaptation en déficience physique de Québec, Québec, CanadaInstitut de réadaptation en déficience physique de Québec, Québec, CanadaDepartment of Physical Medicine and Rehabilitation, College of Medicine, Yeungnam University 317-1, Daemyungdong, Namku, Taegu 705-717, Republic of KoreaMovement disorders post-amputation are a rare complication and can manifest as the jumping stump phenomenon, a form of peripheral myoclonus. The pathophysiology remains unknown and there is currently no standardized treatment. We describe the case of a 57-year-old male with unremitting stump myoclonus, starting one month after transtibial amputation, in his residual limb without associated phantom or neurological pain. The consequence of the myoclonus was a reduction in prosthetic wearing time. Failure to respond to oral medication led us to attempt the use of botulinum neurotoxin Type A injections in the involved muscles of the residual limb. Injection trials, over a two-year period, resulted in an improvement of movement disorder, an increased prosthetic wearing time and a higher satisfaction level of the patient. Injection of botulinum toxin type A should be considered as an alternative treatment for stump myoclonus to improve prosthetic wearing time and comfort.https://doi.org/10.1515/tnsci-2020-0006amputation stumpmyoclonusmovement disordersbotulinum toxin
collection DOAJ
language English
format Article
sources DOAJ
author Briand Marie-Michèle
Boudier-Réveret Mathieu
Rodrigue Xavier
Sirois Geneviève
Chang Min Cheol
spellingShingle Briand Marie-Michèle
Boudier-Réveret Mathieu
Rodrigue Xavier
Sirois Geneviève
Chang Min Cheol
A Moving Residual Limb: Botulinum Toxin to the Rescue
Translational Neuroscience
amputation stump
myoclonus
movement disorders
botulinum toxin
author_facet Briand Marie-Michèle
Boudier-Réveret Mathieu
Rodrigue Xavier
Sirois Geneviève
Chang Min Cheol
author_sort Briand Marie-Michèle
title A Moving Residual Limb: Botulinum Toxin to the Rescue
title_short A Moving Residual Limb: Botulinum Toxin to the Rescue
title_full A Moving Residual Limb: Botulinum Toxin to the Rescue
title_fullStr A Moving Residual Limb: Botulinum Toxin to the Rescue
title_full_unstemmed A Moving Residual Limb: Botulinum Toxin to the Rescue
title_sort moving residual limb: botulinum toxin to the rescue
publisher De Gruyter
series Translational Neuroscience
issn 2081-6936
publishDate 2020-02-01
description Movement disorders post-amputation are a rare complication and can manifest as the jumping stump phenomenon, a form of peripheral myoclonus. The pathophysiology remains unknown and there is currently no standardized treatment. We describe the case of a 57-year-old male with unremitting stump myoclonus, starting one month after transtibial amputation, in his residual limb without associated phantom or neurological pain. The consequence of the myoclonus was a reduction in prosthetic wearing time. Failure to respond to oral medication led us to attempt the use of botulinum neurotoxin Type A injections in the involved muscles of the residual limb. Injection trials, over a two-year period, resulted in an improvement of movement disorder, an increased prosthetic wearing time and a higher satisfaction level of the patient. Injection of botulinum toxin type A should be considered as an alternative treatment for stump myoclonus to improve prosthetic wearing time and comfort.
topic amputation stump
myoclonus
movement disorders
botulinum toxin
url https://doi.org/10.1515/tnsci-2020-0006
work_keys_str_mv AT briandmariemichele amovingresiduallimbbotulinumtoxintotherescue
AT boudierreveretmathieu amovingresiduallimbbotulinumtoxintotherescue
AT rodriguexavier amovingresiduallimbbotulinumtoxintotherescue
AT siroisgenevieve amovingresiduallimbbotulinumtoxintotherescue
AT changmincheol amovingresiduallimbbotulinumtoxintotherescue
AT briandmariemichele movingresiduallimbbotulinumtoxintotherescue
AT boudierreveretmathieu movingresiduallimbbotulinumtoxintotherescue
AT rodriguexavier movingresiduallimbbotulinumtoxintotherescue
AT siroisgenevieve movingresiduallimbbotulinumtoxintotherescue
AT changmincheol movingresiduallimbbotulinumtoxintotherescue
_version_ 1717783614506139648